Medtronic Hopes CMS’ Inpatient Payment Shift Will Reverse ICD Slowdown
This article was originally published in The Gray Sheet
Executive SummaryMedtronic is banking on CMS' decision to soften proposed reimbursement cuts to turn around its struggling cardiac rhythm management business
You may also be interested in...
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.